Literature DB >> 19764949

Potential donor-recipient MYH9 genotype interactions in posttransplant nephrotic syndrome after pediatric kidney transplantation.

B I Freedman1, S K Nagaraj, J-J Lin, M D Gautreaux, D W Bowden, S S Iskandar, R J Stratta, J Rogers, E L Hartmann, A C Farney, A M Reeves-Daniel.   

Abstract

Recurrence of focal segmental glomerulosclerosis (FSGS) with nephrotic syndrome is relatively common after kidney transplantation in young recipients whose predialysis course consists of heavy proteinuria, hypertension and subacute loss of kidney function. The gene(s) mediating this effect remain unknown. We report an unusual circumstance where kidneys recovered from a deceased African American male donor with MYH9-related occult FSGS (risk variants in seven of eight MYH9 E1 haplotype single nucleotide polymorphisms) were transplanted into an African American male child with risk variants in four MYH9 E1 risk variants and a European American female teenager with two MYH9 E1 risk variants. Fulminant nephrotic syndrome rapidly developed in the African American recipient, whereas the European American had an uneventful posttransplant course. The kidney donor lacked significant proteinuria at the time of organ procurement. This scenario suggests that donor-recipient interactions in MYH9, as well as other gene-gene and gene-environment interactions, may lead to recurrent nephrotic syndrome after renal transplantation. The impact of transplanting kidneys from donors with multiple MYH9 risk alleles into recipients with similar genetic background at high risk for recurrent kidney disease needs to be determined.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19764949      PMCID: PMC2919765          DOI: 10.1111/j.1600-6143.2009.02806.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  12 in total

1.  MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis.

Authors:  Jeffrey B Kopp; Michael W Smith; George W Nelson; Randall C Johnson; Barry I Freedman; Donald W Bowden; Taras Oleksyk; Louise M McKenzie; Hiroshi Kajiyama; Tejinder S Ahuja; Jeffrey S Berns; William Briggs; Monique E Cho; Richard A Dart; Paul L Kimmel; Stephen M Korbet; Donna M Michel; Michele H Mokrzycki; Jeffrey R Schelling; Eric Simon; Howard Trachtman; David Vlahov; Cheryl A Winkler
Journal:  Nat Genet       Date:  2008-09-14       Impact factor: 38.330

2.  Focal segmental glomerulosclerosis: a need for caution in live-related renal transplantation.

Authors:  M P Winn; A M Alkhunaizi; W M Bennett; R L Garber; D N Howell; D W Butterly; P J Conlon
Journal:  Am J Kidney Dis       Date:  1999-05       Impact factor: 8.860

Review 3.  Recurrence of focal-segmental glomerulosclerosis in children after renal transplantation: clinical and genetic aspects.

Authors:  Stefanie Weber; Burkhard Tönshoff
Journal:  Transplantation       Date:  2005-09-27       Impact factor: 4.939

4.  Clinical features and mutational survey of NPHS2 (podocin) in Japanese children with focal segmental glomerulosclerosis who underwent renal transplantation.

Authors:  Takeki Furue; Motoshi Hattori; Hiroyasu Tsukaguchi; Akiko Kitamura; Tae Oomori; Daisuke Ogino; Hyogo Nakakura; Akira Ashida; Kenichiro Miura; Masataka Hisano; Kazuhiro Takahashi; Hiroko Chikamoto; Yuko Akioka; Takashi Sakano
Journal:  Pediatr Transplant       Date:  2008-01-16

5.  Genome-wide linkage analysis of serum creatinine in three isolated European populations.

Authors:  Cristian Pattaro; Yurii S Aulchenko; Aaron Isaacs; Veronique Vitart; Caroline Hayward; Christopher S Franklin; Ozren Polasek; Ivana Kolcic; Zrinka Biloglav; Susan Campbell; Nick Hastie; Gordan Lauc; Thomas Meitinger; Ben A Oostra; Ulf Gyllensten; James F Wilson; Irene Pichler; Andrew A Hicks; Harry Campbell; Alan F Wright; Igor Rudan; Cornelia M van Duijn; Peter Riegler; Fabio Marroni; Peter P Pramstaller
Journal:  Kidney Int       Date:  2009-04-22       Impact factor: 10.612

6.  Recurrence of focal segmental glomerulosclerosis after renal transplantation in patients with mutations of podocin.

Authors:  Roberta Bertelli; Fabrizio Ginevri; Gianluca Caridi; Monica Dagnino; Silvio Sandrini; Marco Di Duca; Francesco Emma; Simone Sanna-Cherchi; Francesco Scolari; Tauro Maria Neri; Luisa Murer; Laura Massella; Giancarlo Basile; Gianfranco Rizzoni; Francesco Perfumo; Gian Marco Ghiggeri
Journal:  Am J Kidney Dis       Date:  2003-06       Impact factor: 8.860

7.  Investigation of intrarenal viral infections in kidney transplant recipients unveils an association between parvovirus B19 and chronic allograft injury.

Authors:  Luisa Barzon; Luisa Murer; Monia Pacenti; Maria Angela Biasolo; Manuela Della Vella; Elisa Benetti; Giovanni Franco Zanon; Giorgio Palù
Journal:  J Infect Dis       Date:  2009-02-01       Impact factor: 5.226

8.  MYH9 is associated with nondiabetic end-stage renal disease in African Americans.

Authors:  W H Linda Kao; Michael J Klag; Lucy A Meoni; David Reich; Yvette Berthier-Schaad; Man Li; Josef Coresh; Nick Patterson; Arti Tandon; Neil R Powe; Nancy E Fink; John H Sadler; Matthew R Weir; Hanna E Abboud; Sharon G Adler; Jasmin Divers; Sudha K Iyengar; Barry I Freedman; Paul L Kimmel; William C Knowler; Orly F Kohn; Kristopher Kramp; David J Leehey; Susanne B Nicholas; Madeleine V Pahl; Jeffrey R Schelling; John R Sedor; Denyse Thornley-Brown; Cheryl A Winkler; Michael W Smith; Rulan S Parekh
Journal:  Nat Genet       Date:  2008-09-14       Impact factor: 38.330

9.  Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclerosis.

Authors:  V J Savin; R Sharma; M Sharma; E T McCarthy; S K Swan; E Ellis; H Lovell; B Warady; S Gunwar; A M Chonko; M Artero; F Vincenti
Journal:  N Engl J Med       Date:  1996-04-04       Impact factor: 91.245

Review 10.  Pathophysiology of focal segmental glomerulosclerosis.

Authors:  Kimberly Reidy; Frederick J Kaskel
Journal:  Pediatr Nephrol       Date:  2007-01-10       Impact factor: 3.714

View more
  7 in total

1.  Candidate genes for non-diabetic ESRD in African Americans: a genome-wide association study using pooled DNA.

Authors:  Meredith A Bostrom; Lingyi Lu; Jeff Chou; Pamela J Hicks; Jianzhao Xu; Carl D Langefeld; Donald W Bowden; Barry I Freedman
Journal:  Hum Genet       Date:  2010-06-08       Impact factor: 4.132

Review 2.  Potential effects of MYH9-associated nephropathy on dialysis and kidney transplant outcomes.

Authors:  Barry I Freedman; Mariana Murea
Journal:  Semin Dial       Date:  2010-05-10       Impact factor: 3.455

3.  African American living-kidney donors should be screened for APOL1 risk alleles.

Authors:  David M Cohen; Anuja Mittalhenkle; David L Scott; Carlton J Young; Douglas J Norman
Journal:  Transplantation       Date:  2011-10-15       Impact factor: 4.939

4.  The APOL1 gene and allograft survival after kidney transplantation.

Authors:  A M Reeves-Daniel; J A DePalma; A J Bleyer; M V Rocco; M Murea; P L Adams; C D Langefeld; D W Bowden; P J Hicks; R J Stratta; J-J Lin; D F Kiger; M D Gautreaux; J Divers; B I Freedman
Journal:  Am J Transplant       Date:  2011-04-12       Impact factor: 8.086

Review 5.  Hereditary nephrotic syndrome: a systematic approach for genetic testing and a review of associated podocyte gene mutations.

Authors:  Geneviève Benoit; Eduardo Machuca; Corinne Antignac
Journal:  Pediatr Nephrol       Date:  2010-03-24       Impact factor: 3.714

6.  Effect of donor non-muscle myosin heavy chain (MYH9) gene polymorphisms on clinically relevant kidney allograft dysfunction.

Authors:  Joanna Pazik; Monika Oldak; Dominika Oziębło; Dominika Dęborska Materkowska; Anna Sadowska; Jacek Malejczyk; Magdalena Durlik
Journal:  BMC Nephrol       Date:  2020-09-01       Impact factor: 2.388

7.  Initial steroid sensitivity in children with steroid-resistant nephrotic syndrome predicts post-transplant recurrence.

Authors:  Wen Y Ding; Ania Koziell; Hugh J McCarthy; Agnieszka Bierzynska; Murali K Bhagavatula; Jan A Dudley; Carol D Inward; Richard J Coward; Jane Tizard; Christopher Reid; Corinne Antignac; Olivia Boyer; Moin A Saleem
Journal:  J Am Soc Nephrol       Date:  2014-02-07       Impact factor: 10.121

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.